Adipocytes: Impact on tumor growth and potential sites for therapeutic intervention

Simona Hefetz-Sela, Philipp E. Scherer

Research output: Contribution to journalArticle

61 Citations (Scopus)

Abstract

The prevalence of obesity has increased dramatically in recent decades, reaching epidemic proportions. It is becoming clear that obesity is associated not only with type 2 diabetes mellitus and cardiovascular disease, but also with multiple types of cancer. Obesity is characterized by impaired adipose tissue function, leading to adipocyte hypertrophy, inflammation, hypoxia and induced angiogenesis, extracellular matrix remodeling and fibrosis as well as additional stress responses. While epidemiological data indicate that obesity is a well-established risk factor for certain malignancies, the molecular mechanisms underlying the link between obesity and cancer are still poorly understood. Recent data implicates systemic and paracrine factors secreted from adipose tissue during the obese state, promoting cancer development and progression. Here, we focus on the obesity-associated adipose tissue remodeling that may not only lead to metabolic complications, but also to a permissive pro-tumorigenic environment. Particular attention is given to the local pro-tumorigenic effects derived from adipocytes that present an important part of the tumor microenvironment of at least some cancers, in an attempt to describe the nature of the major players of the adipocyte-cancer cell crosstalk that dictates to a large extent tumor progression.

Original languageEnglish (US)
Pages (from-to)197-210
Number of pages14
JournalPharmacology and Therapeutics
Volume138
Issue number2
DOIs
StatePublished - May 2013

Fingerprint

Adipocytes
Obesity
Growth
Neoplasms
Adipose Tissue
Therapeutics
Tumor Microenvironment
Type 2 Diabetes Mellitus
Hypertrophy
Extracellular Matrix
Fibrosis
Cardiovascular Diseases
Inflammation

Keywords

  • Adipocyte
  • Cancer metabolism
  • Obesity
  • Stromal compartment

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this

Adipocytes : Impact on tumor growth and potential sites for therapeutic intervention. / Hefetz-Sela, Simona; Scherer, Philipp E.

In: Pharmacology and Therapeutics, Vol. 138, No. 2, 05.2013, p. 197-210.

Research output: Contribution to journalArticle

@article{0d1c8977bdd24f959071916fe6fc7e35,
title = "Adipocytes: Impact on tumor growth and potential sites for therapeutic intervention",
abstract = "The prevalence of obesity has increased dramatically in recent decades, reaching epidemic proportions. It is becoming clear that obesity is associated not only with type 2 diabetes mellitus and cardiovascular disease, but also with multiple types of cancer. Obesity is characterized by impaired adipose tissue function, leading to adipocyte hypertrophy, inflammation, hypoxia and induced angiogenesis, extracellular matrix remodeling and fibrosis as well as additional stress responses. While epidemiological data indicate that obesity is a well-established risk factor for certain malignancies, the molecular mechanisms underlying the link between obesity and cancer are still poorly understood. Recent data implicates systemic and paracrine factors secreted from adipose tissue during the obese state, promoting cancer development and progression. Here, we focus on the obesity-associated adipose tissue remodeling that may not only lead to metabolic complications, but also to a permissive pro-tumorigenic environment. Particular attention is given to the local pro-tumorigenic effects derived from adipocytes that present an important part of the tumor microenvironment of at least some cancers, in an attempt to describe the nature of the major players of the adipocyte-cancer cell crosstalk that dictates to a large extent tumor progression.",
keywords = "Adipocyte, Cancer metabolism, Obesity, Stromal compartment",
author = "Simona Hefetz-Sela and Scherer, {Philipp E.}",
year = "2013",
month = "5",
doi = "10.1016/j.pharmthera.2013.01.008",
language = "English (US)",
volume = "138",
pages = "197--210",
journal = "Pharmacology and Therapeutics",
issn = "0163-7258",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Adipocytes

T2 - Impact on tumor growth and potential sites for therapeutic intervention

AU - Hefetz-Sela, Simona

AU - Scherer, Philipp E.

PY - 2013/5

Y1 - 2013/5

N2 - The prevalence of obesity has increased dramatically in recent decades, reaching epidemic proportions. It is becoming clear that obesity is associated not only with type 2 diabetes mellitus and cardiovascular disease, but also with multiple types of cancer. Obesity is characterized by impaired adipose tissue function, leading to adipocyte hypertrophy, inflammation, hypoxia and induced angiogenesis, extracellular matrix remodeling and fibrosis as well as additional stress responses. While epidemiological data indicate that obesity is a well-established risk factor for certain malignancies, the molecular mechanisms underlying the link between obesity and cancer are still poorly understood. Recent data implicates systemic and paracrine factors secreted from adipose tissue during the obese state, promoting cancer development and progression. Here, we focus on the obesity-associated adipose tissue remodeling that may not only lead to metabolic complications, but also to a permissive pro-tumorigenic environment. Particular attention is given to the local pro-tumorigenic effects derived from adipocytes that present an important part of the tumor microenvironment of at least some cancers, in an attempt to describe the nature of the major players of the adipocyte-cancer cell crosstalk that dictates to a large extent tumor progression.

AB - The prevalence of obesity has increased dramatically in recent decades, reaching epidemic proportions. It is becoming clear that obesity is associated not only with type 2 diabetes mellitus and cardiovascular disease, but also with multiple types of cancer. Obesity is characterized by impaired adipose tissue function, leading to adipocyte hypertrophy, inflammation, hypoxia and induced angiogenesis, extracellular matrix remodeling and fibrosis as well as additional stress responses. While epidemiological data indicate that obesity is a well-established risk factor for certain malignancies, the molecular mechanisms underlying the link between obesity and cancer are still poorly understood. Recent data implicates systemic and paracrine factors secreted from adipose tissue during the obese state, promoting cancer development and progression. Here, we focus on the obesity-associated adipose tissue remodeling that may not only lead to metabolic complications, but also to a permissive pro-tumorigenic environment. Particular attention is given to the local pro-tumorigenic effects derived from adipocytes that present an important part of the tumor microenvironment of at least some cancers, in an attempt to describe the nature of the major players of the adipocyte-cancer cell crosstalk that dictates to a large extent tumor progression.

KW - Adipocyte

KW - Cancer metabolism

KW - Obesity

KW - Stromal compartment

UR - http://www.scopus.com/inward/record.url?scp=84875227258&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875227258&partnerID=8YFLogxK

U2 - 10.1016/j.pharmthera.2013.01.008

DO - 10.1016/j.pharmthera.2013.01.008

M3 - Article

C2 - 23353703

AN - SCOPUS:84875227258

VL - 138

SP - 197

EP - 210

JO - Pharmacology and Therapeutics

JF - Pharmacology and Therapeutics

SN - 0163-7258

IS - 2

ER -